Cargando…
CMTM7 inhibits breast cancer progression by regulating Wnt/β-catenin signaling
BACKGROUND: Breast cancer is the major cause of death in females globally. Chemokine-like factor like MARVEL transmembrane domain containing 7 (CMTM7) is reported as a tumor suppressor and is involved in epidermal growth factor receptor degradation and PI3K/AKT signaling in previous studies. However...
Autores principales: | Chen, Zhao-Hui, Tian, Yao, Zhou, Guang-Lei, Yue, Hao-Ran, Zhou, Xue-Jie, Ma, Hai-Yan, Ge, Jie, Wang, Xin, Cao, Xu-Chen, Yu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960403/ https://www.ncbi.nlm.nih.gov/pubmed/36829181 http://dx.doi.org/10.1186/s13058-023-01620-9 |
Ejemplares similares
-
CMTM8 inhibits the carcinogenesis and progression of bladder cancer
por: GAO, DENGHUI, et al.
Publicado: (2015) -
Expressions of ZNF436, β-catenin, EGFR, and CMTM5 in breast cancer and their clinical significances
por: Chen, Zhi, et al.
Publicado: (2021) -
Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer
por: Chen, Xiaojun, et al.
Publicado: (2015) -
TROAP regulates cell cycle and promotes tumor progression through Wnt/β‐Catenin signaling pathway in glioma cells
por: Zhao, Zong‐qing, et al.
Publicado: (2021) -
CMTM3 as a Potential New Immune Checkpoint Regulator
por: Shen, Qian, et al.
Publicado: (2022)